Guardant Health (GH) Long-Term Investments (2017 - 2022)

Guardant Health has disclosed Long-Term Investments across 6 years of filings, most recently posting $156.7 million for Q3 2022.

• In Q3 2022, Long-Term Investments fell 37.36% year-over-year to $156.7 million; the TTM figure through Sep 2022 stood at $156.7 million (down 37.36% YoY), while the FY2021 annual figure was $698.0 million, up 183.07% from the prior year.
• Long-Term Investments came in at $156.7 million for Q3 2022 at Guardant Health, down from $382.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $698.0 million in Q4 2021 to a low of $3.0 million in Q3 2018.
• Average Long-Term Investments over 5 years is $235.6 million, with a median of $242.4 million recorded in 2020.
• Year-over-year, Long-Term Investments surged 10113.43% in 2019 and sank 83.02% in 2020.
• Over 5 years, Long-Term Investments stood at $77.6 million in 2018, then soared by 246.54% to $268.8 million in 2019, then fell by 8.25% to $246.6 million in 2020, then jumped by 183.07% to $698.0 million in 2021, then sank by 77.55% to $156.7 million in 2022.
• Per Business Quant data, the three most recent Long-Term Investments figures were $156.7 million in Q3 2022, $382.6 million in Q2 2022, and $588.5 million in Q1 2022.